Restoring Skeletal Muscle Health through Exercise in Breast Cancer Patients and after Receiving Chemotherapy
- PMID: 39062775
- PMCID: PMC11277416
- DOI: 10.3390/ijms25147533
Restoring Skeletal Muscle Health through Exercise in Breast Cancer Patients and after Receiving Chemotherapy
Abstract
Breast cancer (BC) stands out as the most commonly type of cancer diagnosed in women worldwide, and chemotherapy, a key component of treatment, exacerbates cancer-induced skeletal muscle wasting, contributing to adverse health outcomes. Notably, the impact of chemotherapy on skeletal muscle seems to surpass that of the cancer itself, with inflammation identified as a common trigger for muscle wasting in both contexts. In skeletal muscle, pro-inflammatory cytokines modulate pathways crucial for the delicate balance between protein synthesis and breakdown, as well as satellite cell activation and myonuclear accretion. Physical exercise consistently emerges as a crucial therapeutic strategy to counteract cancer and chemotherapy-induced muscle wasting, ultimately enhancing patients' quality of life. However, a "one size fits all" approach does not apply to the prescription of exercise for BC patients, with factors such as age, menopause and comorbidities influencing the response to exercise. Hence, tailored exercise regimens, considering factors such as duration, frequency, intensity, and type, are essential to maximize efficacy in mitigating muscle wasting and improving disease outcomes. Despite the well-established anti-inflammatory role of aerobic exercise, resistance exercise proves equally or more beneficial in terms of mass and strength gain, as well as enhancing quality of life. This review comprehensively explores the molecular pathways affected by distinct exercise regimens in the skeletal muscle of cancer patients during chemotherapy, providing critical insights for precise exercise implementation to prevent skeletal muscle wasting.
Keywords: aerobic exercise; mammary tumorigenesis; metabolic remodeling; muscle wasting; physical activity; resistance training.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
Myogenic microRNAs as Therapeutic Targets for Skeletal Muscle Mass Wasting in Breast Cancer Models.Int J Mol Sci. 2024 Jun 18;25(12):6714. doi: 10.3390/ijms25126714. Int J Mol Sci. 2024. PMID: 38928418 Free PMC article. Review.
-
Muscle strength, body composition, and physical activity in women receiving chemotherapy for breast cancer.Integr Cancer Ther. 2006 Sep;5(3):183-91. doi: 10.1177/1534735406291962. Integr Cancer Ther. 2006. PMID: 16880422 Review.
-
Exercise as an anti-inflammatory therapy for cancer cachexia: a focus on interleukin-6 regulation.Am J Physiol Regul Integr Comp Physiol. 2020 Feb 1;318(2):R296-R310. doi: 10.1152/ajpregu.00147.2019. Epub 2019 Dec 11. Am J Physiol Regul Integr Comp Physiol. 2020. PMID: 31823669 Review.
-
Optitrain: a randomised controlled exercise trial for women with breast cancer undergoing chemotherapy.BMC Cancer. 2017 Feb 6;17(1):100. doi: 10.1186/s12885-017-3079-x. BMC Cancer. 2017. PMID: 28166765 Free PMC article. Clinical Trial.
-
Long-term exercise training prevents mammary tumorigenesis-induced muscle wasting in rats through the regulation of TWEAK signalling.Acta Physiol (Oxf). 2017 Apr;219(4):803-813. doi: 10.1111/apha.12721. Epub 2016 Jun 27. Acta Physiol (Oxf). 2017. PMID: 27228549
Cited by
-
Risk factors for breast cancer recurrence in postmenopausal women: a bibliometric study.Front Oncol. 2025 Apr 1;15:1522713. doi: 10.3389/fonc.2025.1522713. eCollection 2025. Front Oncol. 2025. PMID: 40236653 Free PMC article.
-
The Effect of Resistance and/or Aerobic Training on Quality of Life, Fitness, and Body Composition in Prostate Cancer Patients-A Systematic Review and Meta-Analysis.Cancers (Basel). 2024 Dec 23;16(24):4286. doi: 10.3390/cancers16244286. Cancers (Basel). 2024. PMID: 39766184 Free PMC article. Review.
-
Mechanisms, assessment, and exercise interventions for skeletal muscle dysfunction post-chemotherapy in breast cancer: from inflammation factors to clinical practice.Front Oncol. 2025 Mar 4;15:1551561. doi: 10.3389/fonc.2025.1551561. eCollection 2025. Front Oncol. 2025. PMID: 40104495 Free PMC article. Review.
-
Synergy of Body Composition, Exercise Oncology, and Pharmacokinetics: A Narrative Review of Personalizing Paclitaxel Treatment for Breast Cancer.Cancers (Basel). 2025 Apr 9;17(8):1271. doi: 10.3390/cancers17081271. Cancers (Basel). 2025. PMID: 40282447 Free PMC article. Review.
References
-
- Torti F.M., Bristow M.M., Lum B.L., Carter S.K., Howes A.E., Aston D.A., Brown B.W., Hannigan J.F., Meyers F.J., Mitchell E.P. Cardiotoxicity of Epirubicin and Doxorubicin: Assessment by Endomyocardial Biopsy. Cancer Res. 1986;46:3722–3727. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical